Ali Ebrahimi, MD
Interventional Cardiology · Birmingham, ALNPI 1467864827
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.7%), travel and lodging and grants — rather than concentrated in one kind of arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 23.2%. Reporting peaked in 2024 at $19,544 and has fallen 71.6% since, to $5,558 in 2025. Among interventional cardiology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 733 payments — averaging $75.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$13K
- Abbott$10K
- Medtronic$8K
- Angiodynamics, Inc.$7K
- Penumbra, Inc.$3K
- Edwards Lifesciences$3K
- plus $11K from 23 others
Across 1 payment — averaging $49.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$50
What the payments were for
- Grants$13,83825%
- Travel & lodging$14,49626%
- Food & beverage$25,80847%
- Education$1,0922%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 51 | $12,797 |
| Abbott | 107 | $10,421 |
| Medtronic | 252 | $8,173 |
| Angiodynamics, Inc. | 34 | $7,095 |
| Penumbra, Inc. | 15 | $3,323 |
| Edwards Lifesciences | 84 | $2,808 |
| Inari Medical, Inc. | 12 | $2,509 |
| Philips North America LLC | 16 | $2,248 |
| Abiomed | 17 | $1,117 |
| Cardiovascular Systems Inc. | 28 | $1,053 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 64 | $998 |
| Shockwave Medical, Inc | 10 | $818 |
| Johnson & Johnson | 15 | $426 |
| AstraZeneca | 6 | $294 |
| ZOLL Circulation Inc | 2 | $181 |
| Chiesi USA, Inc. | 3 | $159 |
| Cardiva Medical, Inc. | 1 | $118 |
| Biotronik Inc. | 4 | $116 |
| Cook Medical LLC | 1 | $115 |
| Esperion Therapeutics, Inc. | 1 | $109 |
| W. L. Gore & Associates, Inc. | 1 | $69 |
| Cordis US CORP. | 1 | $65 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Cathworks, Inc. | 1 | $41 |
| Stryker | 2 | $39 |
| Teleflex LLC | 1 | $33 |
| Heartflow, Inc. | 1 | $25 |
| Bayer | 1 | $24 |
| Mylan Specialty L.p. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AngioVac$6,452
- COREVALVE EVOLUT R$3,336
- Indigo System$3,033
- FLOWTRIEVER CATHETER, S$2,935
- WATCHMAN Access System$2,079
- CT THROMBECTOMY SYSTEM KIT$1,743
- SAPIEN 3 Ultra RESILIA$1,349
- VersaCross Access Solution$1,309
- Impella$907
- OMNILINK ELITE$867
- SYMPLICITY G3$838
- (9520) IGT Devices Undivided$743
- (6574) Coronary Other$544
- Supera peripheral stent system$339
- Peripheral Orbital Atherectomy System$323
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$315
- EVOQUE$307
- WATCHMAN FLX$294
- XARELTO$236
- Diamondback Coronary$231
How this compares
$55,235 in reported general payments places this provider in the 90th percentile of 109 interventional cardiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $9,102 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Birmingham
- Gary RoubinBirmingham$157K
- Robert FosterBirmingham$90K
- Hasan GuvenBirmingham$86K
- Abdullah MahmoodBirmingham$61K
- Jacob TownsendBirmingham$52K
- Kamran AliBirmingham$47K
- Mouhamed SabouniBirmingham$44K
- David SchultzBirmingham$19K
- Tushar MishraBirmingham$17K
- Arka ChatterjeeBirmingham$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.